Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Autologous blood transfusion in oral and maxillofacial surgery patients with the use of erythropoietin
Autore:
Christopoulou, M; Derartinian, H; Hatzidimitriou, G; Iatrou, I;
Indirizzi:
Univ Athens, Evangelismos Hosp, Dept Oral & Maxillofacial Surg, Athens, Greece Univ Athens Athens Greece ept Oral & Maxillofacial Surg, Athens, Greece Evangelismos Hosp, Dept Blood Donat, Athens, Greece Evangelismos Hosp Athens Greece Hosp, Dept Blood Donat, Athens, Greece
Titolo Testata:
JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY
fascicolo: 2, volume: 29, anno: 2001,
pagine: 118 - 125
SICI:
1010-5182(200104)29:2<118:ABTIOA>2.0.ZU;2-H
Fonte:
ISI
Lingua:
ENG
Soggetto:
RECOMBINANT-HUMAN-ERYTHROPOIETIN; ORTHOPEDIC-SURGERY; ORTHOGNATHIC SURGERY; JEHOVAH-WITNESS; EPOETIN ALFA; VIRUS; HEPATITIS; DONATION; DONORS; RISK;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Citazioni:
31
Recensione:
Indirizzi per estratti:
Indirizzo: Iatrou, I 40 Asklipiou St, Athens 11471, Greece 40 Asklipiou St Athens Greece 11471 u St, Athens 11471, Greece
Citazione:
M. Christopoulou et al., "Autologous blood transfusion in oral and maxillofacial surgery patients with the use of erythropoietin", J CRAN MAX, 29(2), 2001, pp. 118-125

Abstract

Background: Autologous blood transfusion presents few infectious or immunologic side effects. The aim of the present study was to determine the impact of autologous blood transfusion with or without recombinant human erythropoietin (rHuEPO) in patients who underwent elective maxillofacial operations. Material: Seventy eight consecutive patients (29 men and 49 women) underwent elective maxillofacial operations during the years 1990-95, Study design and Methods: The patients were randomly assigned to three groups: In group 1, 30 patients preoperatively underwent autologous blood predonation with intravenous injection of erythropoietin 600 IU/kg after each blood predonation and autologous blood transfusion intraoperatively; in group 2, 28 patients underwent the same procedure without erythropoietin and in group 3, 20 patients underwent homologous transfusion serving as control group. All patients received ferrous sulphate daily by mouth, preoperatively until one week postoperatively, Results: Group 1 patients showed higher levels of haematocrit, haemoglobin and red blood cell count pre- and postoperatively than the group 2 patients. It was also shown that the use of rHuEPO contributed to an improvement of the blood parameters of the patients in the group 1 compared with those of the patients in groups 2 and 3, (C) 2001 European Association for Cranio-Maxillofacial Surgery.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 01/11/20 alle ore 02:25:25